Concert Pharmaceuticals Initiates Phase 1 Multiple-Ascending Dose Trial of CTP-692 Pharmaceutical Investing
Sorrento Therapeutics Announces Discovery of a Potential Non-Dopaminergic Approach to Controlling Parkinson’s Motor Symptoms Biotech Investing
Outlook Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants Biotech Investing
PreveCeutical Announces Further Results from its Preliminary Screening of Peptides Derived from Blue Scorpion Venom in a Cell-Based Brain Cancer Model Cannabis Investing News
Verona Pharma Granted Key EU Patent for Late-stage COPD Clinical Candidate Ensifentrine Biotech Investing
Myriad Genetics Submits First Module of Premarket Approval Application to FDA for myChoice® HRD CDx Test Genetics Investing
TetraGenetics and ImmunoPrecise Extend Collaboration With Multi-Target Service Agreement Biotech Investing
PhaseBio Announces Global License of PB1023 to Treat Sarcopenia-Related Diseases to ImmunoForge Biotech Investing
Hemostemix Reaches Milestone in the ACP-01 Phase 2 Critical Limb Ischemia Clinical Trial Biotech Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
